RET and medullary thyroid gland carcinoma: RET germline gain-of-function mutations cause predisposition to multiple endocrine neoplasia 2 (MEN2) syndrome, while somatic RET mutations have been found in 40-65% of sporadic medullary thyroid cancers (MTCs) (2–5).